Both by immunoblot and by targeted mass spectrometry on independent samples (Fig 4A and B), Hdac1‐deficient tumor cell lines had more H3K79 methylation than their Hdac1‐proficient counterparts. The gene discussed is HDAC1; the disease is neoplasm.